# Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

> **NCT02064036** · PHASE1 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 17 (actual)

## Conditions studied

- Adenocarcinoma of the Prostate

## Interventions

- **RADIATION:** Stereotactic Radiosurgical Boost
- **DRUG:** Casodex
- **DRUG:** Leuprolide

## Key facts

- **NCT ID:** NCT02064036
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06-06
- **Primary completion:** 2020-12-03
- **Final completion:** 2021-10-29
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02064036

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02064036, "Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT02064036. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*